Ligand dimensions are important in controlling NK-cell responses

European Journal of Immunology

Volumn 40, Issue 7, 2010, Pages 2050-2059

  Brzostek, Joanna ^a   Chai, Jian Guo ^a   Gebhardt, Friedemann ^b   Busch, Dirk H ^b   Zhao, Rui ^c   Van Der Merwe, P Anton ^d   Gould, Keith G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c BABRAHAM INSTITUTE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cell surface molecules NK cells; Cellular activation; NK cell ligands

Indexed keywords

INTERLEUKIN 2; LYSINE; NATURAL KILLER CELL RECEPTOR NKG2D; H-2KB PROTEIN, MOUSE; H2 ANTIGEN; KLRK1 PROTEIN, MOUSE; LIGAND; MINOR H ANTIGEN H60; MINOR HISTOCOMPATIBILITY ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ELONGATION; CELL FUNCTION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CHO CELL LINE; CRICETULUS; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; SITE DIRECTED MUTAGENESIS; TRANSGENE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; CYTOTOXICITY, IMMUNOLOGIC; H-2 ANTIGENS; KILLER CELLS, NATURAL; LIGANDS; MICE; MICE, INBRED C57BL; MINOR HISTOCOMPATIBILITY ANTIGENS; MUTAGENESIS, INSERTIONAL; MUTAGENESIS, SITE-DIRECTED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROTEIN BINDING; TRANSGENES;

EID: 77954112215     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040335     Document Type: Article

References (34)

1. Springer, T. A., Adhesion receptors of the immune system. Nature 1990. 346: 425-434.
2. Choudhuri, K.,Wiseman, D., Brown, M. H., Gould, K. and van der Merwe, P. A., T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature 2005. 436: 578-582.
3. Choudhuri, K., Parker, M., Milicic, A., Cole, D. K., Shaw, M. K., Sewell, A. K., Stewart-Jones, G. et al., Peptide-major histocompatibility complex dimensions control proximal kinase-phosphatase balance during T cell activation. J. Biol. Chem. 2009. 284: 26096-26105.
4. Hombach, A. A., Schildgen, V., Heuser, C., Finnern, R., Gilham, D. E. and Abken, H., T cell activation by antibody-like immunoreceptors: the position of the binding epitope within the target molecule determines the efficiency of activation of redirected T cells. J. Immunol. 2007. 178: 4650-4657. (Pubitemid 46492418)
5. Wild, M. K., Cambiaggi, A., Brown, M. H., Davies, E. A., Ohno, H., Saito, T. and van der Merwe, P. A., Dependence of T cell antigen recognition on the dimensions of an accessory receptor-ligand complex. J. Exp. Med. 1999. 190: 31-41.
6. Milstein, O., Tseng, S. Y., Starr, T., Llodra, J., Nans, A., Liu, M.,Wild, M. K. et al., Nanoscale increases in CD2-CD48-mediated intermembrane spacing decrease adhesion and reorganize the immunological synapse. J. Biol. Chem. 2008. 283: 34414-34422.
7. Irles, C., Symons, A., Michel, F., Bakker, T. R., van der Merwe, P. A. and Acuto, O., CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling. Nat. Immunol. 2003. 4: 189-197.
8. James, S. E., Greenberg, P. D., Jensen, M. C., Lin, Y., Wang, J., Till, B. G., Raubitschek, A. A. et al., Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane. J. Immunol. 2008. 180: 7028-7038.
9. Malarkannan, S., Shih, P. P., Eden, P. A., Horng, T., Zuberi, A. R., Christianson, G., Roopenian, D. and Shastri, N., The molecular and functional characterization of a dominant minor H antigen, H60. J. Immunol. 1998. 161: 3501-3509.
10. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. and Raulet, D. H., Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 2000. 1: 119-126.
11. Takada, A., Yoshida, S., Kajikawa, M., Miyatake, Y., Tomaru, U., Sakai, M., Chiba, H. et al., Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D. J. Immunol. 2008. 180: 1678-1685.
12. Jamieson, A. M., Diefenbach, A., McMahon, C. W., Xiong, N., Carlyle, J. R. and Raulet, D. H., The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002. 17: 19-29.
13. Upshaw, J. L. and Leibson, P. J., NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes. Semin. Immunol. 2006. 18: 167-175.
14. Davis, S. J. and van der Merwe, P. A., The kinetic-segregation model: TCR triggering and beyond. Nat. Immunol. 2006. 7: 803-809.
15. Byth, K. F., Conroy, L. A., Howlett, S., Smith, A. J., May, J., Alexander, D. R. and Holmes, N., CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+ CD8+ thymocytes, and B cell maturation. J. Exp. Med. 1996. 183: 1707-1718.
16. Hesslein, D. G., Takaki, R., Hermiston, M. L., Weiss, A. and Lanier, L. L., Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc. Natl. Acad. Sci. USA 2006. 103: 7012-7017.
17. Huntington, N. D., Xu, Y., Nutt, S. L. and Tarlinton, D. M., A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells. J. Exp. Med. 2005. 201: 1421-1433.
18. Idris, A. H., Iizuka, K., Smith, H. R., Scalzo, A. A. and Yokoyama, W. M., Genetic control of natural killing and in vivo tumor elimination by the Chok locus. J. Exp. Med. 1998. 188: 2243-2256.
19. Furukawa, H., Iizuka, K., Poursine-Laurent, J., Shastri, N. and Yokoyama, W. M., A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice. J. Immunol. 2002. 169: 126-136. (Pubitemid 34686128)
20. Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y. J., Yang, L., French, A. R. et al., Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005. 436: 709-713.
21. Lu, L., Ikizawa, K., Hu, D., Werneck, M. B., Wucherpfennig, K. W. and Cantor, H., Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 2007. 26: 593-604.
22. Wu, J., Song, Y., Bakker, A. B., Bauer, S., Spies, T., Lanier, L. L. and Phillips, J. H., An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999. 285: 730-732. (Pubitemid 129505075)
23. Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J. and Leibson, P. J., NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat. Immunol. 2003. 4: 557-564.
24. Mason, L. H., Gosselin, P., Anderson, S. K., Fogler,W. E., Ortaldo, J. R. and McVicar, D.W., Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J. Immunol. 1997. 159: 4187-4196.
25. Mason, L. H., Willette-Brown, J., Taylor, L. S. and McVicar, D. W., Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J. Immunol. 2006. 176: 6615-6623.
26. McCann, F. E., Vanherberghen, B., Eleme, K., Carlin, L. M., Newsam, R. J., Goulding, D. and Davis, D. M., The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses. J. Immunol. 2003. 170: 2862-2870.
27. Treanor, B., Lanigan, P. M., Kumar, S., Dunsby, C., Munro, I., Auksorius, E., Culley, F. J. et al., Microclusters of inhibitory killer immunoglobulin-like receptor signaling at natural killer cell immunological synapses. J. Cell Biol. 2006. 174: 153-161.
28. Schleinitz, N., March, M. E. and Long, E. O., Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS ONE 2008. 3: e3278.
29. Long, E. O., Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 2008. 224: 70-84.
30. Coles, M. C., McMahon, C. W., Takizawa, H. and Raulet, D. H., Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur. J. Immunol. 2000. 30: 236-244.
31. Maeda, M., Lohwasser, S., Yamamura, T. and Takei, F., Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line. J. Immunol. 2001. 167: 4180-4186. (Pubitemid 32954290)
32. Ochi, H. and Watanabe, T., Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity. Int. Immunol. 2000. 12: 1417-1423.
33. Dong, Y., Skoultchi, A. I. and Pollard, J. W., Efficient DNA transfection of quiescent mammalian cells using poly-L-ornithine. Nucleic Acids Res. 1993. 21: 771-772. (Pubitemid 23155588)
34. Krmpotic, A., Busch, D. H., Bubic, I., Gebhardt, F., Hengel, H., Hasan, M., Scalzo, A. A. et al., MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat. Immunol. 2002. 3: 529-535.